Literature DB >> 22001052

Adhesion molecule expression and ventricular remodeling in chronic rheumatic heart disease: a cause or effect in the disease progression--a pilot study.

Uma Nahar Saikia1, Rohit Manoj Kumar, V K G Rajasekara Pal Pandian, Shivali Gupta, R S Dhaliwal, K K Talwar.   

Abstract

BACKGROUND: Rheumatic fever and chronic rheumatic heart disease (RHD) remains one of the most important causes of cardiovascular morbidity leading to a major public health problem, especially in developing countries. This was a pilot study to assess the presence of inflammation and expression of adhesion molecules by immunohistochemistry (IHC) in endomyocardial biopsy specimens of patients with chronic RHD.
METHODS: Endomyocardial biopsy was obtained from 14 patients of chronic RHD with no features of activity clinically. Biopsies were processed for histology and IHC. IHC was carried using monoclonal antibodies against CD3, CD4, CD8, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1.
RESULTS: Histomorphologically, varying degree of interstitial and perivascular fibrosis was seen in all the 13 patients (100%). Mild fibrosis (1+) was seen in five patients (38.5%); moderate interstitial fibrosis (2+) was present in four patients (30.8%).There was no Aschoff nodule or evidence of active myocarditis in any of the biopsy specimens. IMMUNOHISTOCHEMISTRY: Moderate positivity of (2+) and intense positivity of (3+) for intercellular adhesion molecule-1 was seen in 11 and 2 patients, respectively. With vascular cell adhesion molecule-1, four showed mild positivity (1+), and three showed intense positivity (3+). The phenotypic analysis of the inflammatory cells in our study revealed CD8(+) cells in 77%, CD4(+) in 23.1%, and CD3(+) in 38.5% of total patients, which suggests chronicity.
CONCLUSION: The nonspecific histomorphological changes and increased adhesion molecules expression could be a part of the ventricular remodeling due to the hemodynamic stress by the stenotic or regurgitant lesions of RHD itself.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001052     DOI: 10.1016/j.carpath.2011.01.005

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  4 in total

Review 1.  Mechanistic implications of altered protein expression in rheumatic heart disease.

Authors:  Evelyn N Lumngwena; Sebastian Skatulla; Jonathan M Blackburn; Ntobeko A B Ntusi
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

2.  A novel human anti-VCAM-1 monoclonal antibody ameliorates airway inflammation and remodelling.

Authors:  Jae-Hyun Lee; Jung-Ho Sohn; Su Yeon Ryu; Chein-Soo Hong; Kyung D Moon; Jung-Won Park
Journal:  J Cell Mol Med       Date:  2013-07-16       Impact factor: 5.310

3.  Evidence of apoptosis in right ventricular dysfunction in rheumatic mitral valve stenosis.

Authors:  Shantanu Pande; Prabhat Tewari; Surendra K Agarwal; Vikas Agarwal; Vinita Agrawal; Megha Chagtoo; Gauranga Majumdar; Satyendra Tewari
Journal:  Indian J Med Res       Date:  2016-11       Impact factor: 2.375

4.  Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.

Authors:  Cheng Liu; Yanxian Lai; Deping Wu; Ruibin Fu; Yanfang Li; Hu Li; Tianwang Guan; Yan Shen
Journal:  ESC Heart Fail       Date:  2021-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.